← Eichor
Condition: Malignant Tumors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Tumors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm
Phase 2 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT04332874Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell
Phase N/A · 19 location(s) · AO Innovation Translation Center · NCT04098146TumorGlow Intraoperative Molecular Imaging (IMI)
Phase 1/Phase 2 · 1 location(s) · University of Pennsylvania · NCT04723810Clinical Application Study of [123I]Metaiodobenzylguanidine and Somatostatin Receptor-Targeted Imaging in the Diagnosis
Phase N/A · 1 location(s) · Nanjing First Hospital, Nanjing Medical University · NCT07064746Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
Phase N/A · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT02280161Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Shanghai Pudong Hospital · NCT06501183Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer
Phase 2 · 1 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06938724Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
Phase 2 · 22 location(s) · Medical University of Vienna · NCT01356290A Study of TIL in Advanced Solid Tumors (DFGD)
EARLY_Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06488950INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies
Phase 1/Phase 2 · 14 location(s) · University Hospital Heidelberg · NCT03838042A Study of CM350 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 2 location(s) · Keymed Biosciences Co.Ltd · NCT05263960The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma
Phase 2 · 1 location(s) · Aalborg University Hospital · NCT06790082Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Phase 3 · 4 location(s) · Mayo Clinic · NCT03750227Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The K
Phase 4 · 1 location(s) · OHSU Knight Cancer Institute · NCT07405086A Phase I/II Clinical Study of CTS3497 in Patients With MTAP Deficient Malignacies
Phase 1/Phase 2 · 1 location(s) · CytosinLab Therapeutics Co., Ltd. · NCT06971523SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid T
Phase 1 · 11 location(s) · Qurgen Inc. · NCT06873659Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70
Phase 1/Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT02830724A Study of HS-20110 in Participants With Advanced Solid Tumors
Phase 1 · 8 location(s) · Hansoh BioMedical R&D Company · NCT06892379Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
Phase 1 · 3 location(s) · Adlai Nortye Biopharma Co., Ltd. · NCT07252479T2 Star Magnetic Resonance Imaging and Biomarker Blood Testing to Predict the Change and Progress of Malignant Gliomas
NA · 1 location(s) · John M. Buatti · NCT07447531Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
Phase N/A · 1 location(s) · Aura Biosciences · NCT07421739Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC.
Phase 1/Phase 2 · 11 location(s) · Chipscreen Biosciences, Ltd. · NCT05271292IL-17 Blockade to Decrease irAEs (REPLAY)
Phase 1 · 1 location(s) · Duke University · NCT07237594Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Phase 1/Phase 2 · 1 location(s) · Peking Union Medical College Hospital · NCT07400224Proof of Concept to Assess the Feasibility of a Decentralised Pathway Coordinated by the Advanced Practice Nurse for Pat
NA · 1 location(s) · Institut Claudius Regaud · NCT06797037SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
Phase 3 · 3 location(s) · Hildur Helgadottir · NCT06794775PSMA in Gastroenterologic Tumors (GIPSMA)
NA · 1 location(s) · Wuerzburg University Hospital · NCT05547919Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Co
NA · 1 location(s) · City of Hope Medical Center · NCT05772130Combined Screening for Gastrointestinal Tumors
Phase N/A · 2 location(s) · Zhejiang Cancer Hospital · NCT06478030A First-in-Human, Phase 1/2 Study of LAT010 in Patients With Advanced Solid Tumors (LIGHTSPEED-1)
Phase 1/Phase 2 · 4 location(s) · Latticon Antibody Therapeutics, Inc · NCT06277219
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.